Breakthrough CAR-T Therapy Shows Promising Outcomes in Patients with Refractory Lymphoma
A groundbreaking advancement in the fight against refractory CD30-positive lymphomas has emerged from researchers at the Sant Pau Research Institute ...
A groundbreaking advancement in the fight against refractory CD30-positive lymphomas has emerged from researchers at the Sant Pau Research Institute ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine